recent
emerg
novel
human
coronaviru
hcovemc
middl
east
rais
consider
concern
associ
sever
acut
pneumonia
renal
failur
fatal
outcom
thu
resembl
clinic
present
sever
acut
respiratori
syndrom
sar
observ
like
sarscov
hcovemc
zoonot
origin
close
relat
bat
coronavirus
human
airway
epithelium
hae
repres
entri
point
primari
target
tissu
respiratori
virus
highli
relev
assess
zoonot
potenti
emerg
respiratori
virus
hcovemc
show
pseudostratifi
hae
cultur
deriv
differ
donor
highli
permiss
hcovemc
infect
use
revers
transcript
rt
pcr
rnaseq
data
experiment
determin
ident
seven
hcovemc
subgenom
mrna
although
hae
cell
readili
respons
type
type
iii
interferon
ifn
observ
neither
pronounc
inflammatori
cytokin
detect
ifn
respons
follow
hcovemc
sarscov
infect
suggest
innat
immun
evas
mechan
put
ifn
antagonist
hcovemc
oper
new
host
importantli
howev
demonstr
type
type
iii
ifn
effici
reduc
hcovemc
replic
hae
cultur
provid
possibl
treatment
option
case
suspect
hcovemc
infect
hcovemc
infect
import
first
barrier
invad
respiratori
pathogen
epithelium
repres
entri
point
primari
target
tissu
respiratori
virus
show
human
bronchial
epithelia
highli
suscept
hcovemc
infect
furthermor
hcovemc
like
coronavirus
evad
innat
immun
recognit
reflect
lack
interferon
minim
inflammatori
cytokin
express
follow
infect
importantli
type
type
iii
interferon
treatment
effici
reduc
hcovemc
replic
human
airway
epithelium
provid
possibl
avenu
treatment
emerg
viru
infect
citat
kindler
e
hr
muth
ham
oj
hartmann
r
rodriguez
r
geffer
r
fouchier
ram
drosten
c
dijkman
r
thiel
v
effici
replic
novel
human
betacoronaviru
emc
primari
human
epithelium
highlight
zoonot
potenti
mbio
replic
hcovemc
sarscov
hae
cultur
hae
cultur
three
donor
black
light
gray
dark
gray
prepar
describ
previous
infect
hcovemc
sarscov
moi
progeni
viru
releas
apic
top
bottom
basolater
middl
surfac
hcovemcor
sarscovinfect
hae
cultur
determin
genom
equival
ge
plaqueform
unit
pfu
per
ml
indic
hpi
use
quantit
realtim
revers
transcriptionpcr
qrtpcr
specif
hcovemc
sarscov
titrat
infecti
particl
vero
cell
experi
perform
triplic
donor
data
depict
mean
valu
standard
deviat
sd
nd
detect
b
hcovemcand
sarscovinfect
moi
mocktreat
hae
cell
cultur
fix
hpi
pfa
immunostain
use
procedur
describ
rabbit
polyclon
antiserum
direct
sarscov
green
antisarscov
antibodi
rockland
mous
monoclon
antibodi
direct
dsrna
red
english
scientif
consult
bt
use
primari
antibodi
dylight
antimous
igg
dylight
antirabbit
igg
jackson
immunoresearch
appli
secondari
antibodi
follow
two
separ
incub
step
mous
antibodi
light
blue
sigma
stain
ciliat
cell
dapi
invitrogen
stain
nuclei
dark
blue
imag
acquir
use
ec
planneofluor
oil
differenti
infer
contrast
dic
object
zeiss
lsm
confoc
microscop
imag
captur
analysi
process
perform
use
zen
zeiss
imari
bitplan
scientif
softwar
softwar
packag
repres
imag
shown
one
three
donor
c
schemat
represent
sequenc
read
rnaseq
analysi
poli
contain
rna
deriv
hcovemcinfect
hae
cultur
moi
hpi
singl
read
depict
green
sens
red
antisens
continu
point
primari
target
tissu
respiratori
virus
assess
zoonot
potenti
hcovemc
therefor
critic
import
determin
human
respiratori
epithelium
suscept
hcovemc
infect
address
question
use
human
airway
epithelium
hae
cultur
morpholog
function
resembl
upper
conduct
airway
vivo
hae
cultur
system
base
primari
human
bronchial
epitheli
cell
obtain
biopsi
brush
surgeri
lung
transplant
isol
bronchial
epitheli
cell
manipul
chemic
defin
medium
initi
differenti
pseudostratifi
human
airway
epitheli
cultur
differenti
complet
pseudostratifi
hae
cell
layer
contain
basal
secretori
columnar
ciliat
cell
popul
ii
gener
mucu
therefor
vitro
system
recapitul
mani
aspect
human
airway
epithelium
name
presenc
welldefin
cell
type
human
airway
epithelium
physic
barrier
mucou
layer
end
infect
fulli
differenti
hae
cultur
deriv
three
differ
donor
hcovemc
sarscov
strain
multipl
infect
moi
assess
viral
growth
kinet
shown
fig
hae
cell
highli
suscept
hcovemc
infect
peak
viru
product
alreadi
h
postinfect
hpi
contrast
replic
sarscov
appear
slower
reach
peak
viru
product
later
hpi
fig
virus
vast
major
progeni
viru
releas
apic
side
hae
cultur
ie
toward
mucou
layer
fig
top
bottom
compar
lower
alway
detect
viru
releas
basolater
side
ie
toward
medium
fig
middl
analyz
hcovemc
sarscov
infect
hae
cultur
immunofluoresc
microscopi
stain
ciliat
cell
doublestrand
ds
rna
marker
infect
cell
replicas
geneencod
nonstructur
protein
marker
coronaviru
replicasetranscriptas
complex
shown
fig
hcovemcinfect
cell
readili
identifi
crossreact
polyclon
antiserum
direct
sarscov
monoclon
antibodi
direct
dsrna
visual
characterist
punctuat
perinuclear
stain
pattern
coronaviru
replicasetranscriptas
complex
hcovemc
infect
predominantli
noncili
cell
suggest
put
receptor
hcovemc
host
cell
entri
like
express
noncili
cell
human
bronchial
epithelium
also
analyz
intracellular
hcovemcderiv
mrna
use
rnaseq
approach
total
rna
hcovemcinfect
hae
cultur
isol
hpi
use
qiagen
rneasi
kit
follow
mrna
subtract
accord
manufactur
protocol
rnaseq
librari
index
illumina
sequenc
run
establish
use
scriptseq
mrnaseq
librari
prepar
kit
epicent
wi
start
ng
mrna
qualityproven
rnaseq
librari
analyz
use
illumina
system
accord
illumina
truseq
protocol
singl
read
truseq
sb
kit
version
cycl
data
analysi
perform
use
clc
genom
workbench
clc
bio
denmark
singleread
map
raw
read
trim
elimin
ambigu
remain
adapt
sequenc
use
read
collect
donor
duplic
experi
total
dataset
fail
map
human
genom
read
align
publish
hcovemc
genom
sequenc
genbank
access
total
read
could
assign
hcovemc
genom
observ
genom
coverag
reflect
characterist
mrna
replic
transcript
pattern
expect
coronaviru
nest
set
viral
mrna
fig
inde
could
identifi
sever
read
repres
leaderbodi
fusion
sequenc
predict
hcovemc
mrna
fig
addit
experiment
determin
revers
transcript
rt
pcr
use
total
rna
hcovemcinfect
hae
cell
leaderbodi
fusion
sequenc
predict
mrna
repres
rnaseq
data
fig
see
also
tabl
supplement
materi
collect
data
show
human
bronchial
epithelium
highli
permiss
hcovemc
infect
accordingli
cellular
factor
requir
cell
entri
eg
receptor
replic
transcript
viral
mrna
viru
assembl
releas
avail
human
host
next
assess
hae
host
cell
respons
hcovemc
infect
transcript
level
compar
respons
sarscov
infect
moi
chose
analyz
express
set
cellular
mrna
see
tabl
supplement
materi
repres
type
ifn
type
iii
ifn
endosom
cytoplasm
rna
sensor
molecul
ifnstimul
gene
isg
chemokin
inflammatori
cytokin
h
follow
type
ifn
iu
type
iii
ifn
ngml
treatment
viru
infect
shown
fig
hae
cultur
respond
swiftli
type
type
iii
ifn
treatment
upregul
isg
express
ie
rigi
fig
notabl
respons
hae
cultur
ifntreat
support
previou
studi
show
high
express
ifnreceptor
lung
epitheli
cell
contrast
ifn
treatment
hae
cultur
display
limit
earli
transcript
respons
coronaviru
infect
particularli
induct
observ
hcovemc
sarscov
cell
fig
also
express
proinflammatori
cytokin
margin
induc
mainli
common
cold
viru
infect
hae
cultur
hpi
thu
immedi
host
respons
hcovemc
infect
hae
cultur
similar
observ
sarscovand
cell
suggest
hcovemc
alreadi
well
adapt
replic
hae
cultur
human
bronchial
epithelium
capabl
mount
strong
innat
immun
respons
absenc
profession
cytokineproduc
cell
plasmacytoid
dendrit
cell
convent
dendrit
cell
macrophag
sinc
hae
cultur
respond
well
type
type
iii
ifn
tabl
supplement
materi
measur
analysi
perform
use
lightcycl
ii
instrument
softwar
packag
roch
cycl
profil
min
cycl
follow
melt
curv
step
confirm
product
specif
rel
gene
express
calcul
use
method
shown
fold
induct
ifntreat
sampl
compar
untreat
control
b
gene
express
analysi
virusinfect
hae
cultur
hae
cell
cultur
infect
hcovemc
sarscov
moi
total
cellular
rna
isol
hpi
rel
gene
express
analysi
perform
describ
c
analysi
viru
replic
follow
ifn
pretreat
hae
cell
cultur
left
untreat
treat
basolater
side
h
recombin
iuml
sigma
recombin
ngml
ngml
basolater
medium
replac
prior
infect
hcovemc
sarscov
moi
apic
progeni
viru
releas
determin
hpi
qrtpcr
given
ge
per
ml
bar
repres
mean
sd
independ
experi
perform
duplic
use
hae
cultur
deriv
three
differ
donor
ns
signific
p
p
p
pair
test
immunofluoresc
analysi
ifntreat
virusinfect
hae
cultur
hae
cultur
fix
pfa
immunostain
use
procedur
describ
mous
monoclon
antibodi
direct
dsrna
english
scientif
consult
bt
appli
primari
antibodi
dylight
antimous
igg
secondari
antibodi
green
jackson
immunoresearch
follow
stain
cilia
mous
antibodi
red
sigma
imag
acquir
use
ec
planneofluor
oil
dic
object
zeiss
confoc
laser
scan
microscop
imag
captur
analysi
process
perform
use
zen
zeiss
imari
bitplan
scientif
softwar
softwar
packag
repres
imag
shown
one
fig
pretreat
hae
cultur
reduc
replic
hcovemc
three
differ
donor
reduc
replic
sarscov
two
three
donor
accordingli
observ
pronounc
reduct
number
dsrnaposit
cell
hae
cultur
infect
hcovemc
sarscov
fig
notabl
pretreat
hae
cultur
also
reduc
replic
hcovemc
sarscov
three
donor
concentr
use
ngml
ngml
like
treatment
observ
pronounc
reduct
number
dsrnaposit
cell
virusinfect
hae
cultur
corrobor
import
type
iii
ifn
epitheli
antivir
host
defens
summari
provid
conclus
evid
novel
coronaviru
hcovemc
product
infect
human
bronchial
epithelia
cultur
suggest
necessari
host
cell
factor
viru
entri
rna
synthesi
viru
assembl
releas
avail
human
host
hcovemc
replic
hae
cultur
least
effici
replic
sarscov
studi
conclud
hcovemc
capabl
infect
primari
target
tissu
human
respiratori
epithelium
accord
report
clinic
present
sever
respiratori
symptom
hcovemc
suggest
zoonot
origin
sinc
close
relat
coronavirus
known
replic
bat
consid
yet
studi
report
success
isol
bat
coronaviru
hcovemc
differ
compar
known
bat
coronavirus
display
broad
replic
capabl
divers
mammalian
cell
line
data
show
highli
pathogen
virus
hcovemc
sarscov
replic
hae
cultur
similar
common
cold
virus
also
earli
host
cell
respons
similar
highand
lowpathogen
human
coronavirus
thu
although
data
depict
zoonot
potenti
hcovemc
demonstr
effici
replic
human
respiratori
epithelium
decis
factor
impact
hcovemc
pathogen
remain
determin
importantli
could
demonstr
hcovemc
replic
equal
vulner
antivir
effect
type
type
iii
ifn
suggest
possibl
interfer
hcovemc
replic
human
respiratori
tract
treatment
inde
explor
therapeut
strategi
sar
epidem
rais
consider
promis
critic
import
type
iii
ifn
epitheli
host
defens
recent
report
treatment
hepat
c
virusinfect
patient
pegyl
ifnachiev
rapid
virolog
respons
advers
side
effect
minim
data
concern
effici
inhibit
hcovemc
replic
encourag
develop
ifntreat
option
specif
respiratori
viru
emerg
viru
infect
supplement
materi
articl
may
found
http
mbioasmorg
tabl
docx
file
mb
tabl
docx
file
mb
